Metabolic syndrome has been widely recognized in various studies as being intricately linked to the initiation and progression of colorectal adenoma. The potential pathways through which metabolic syndrome influences colorectal adenoma encompass chronic inflammation, insulin resistance, oxidative stress, and dysbiosis of the intestinal flora. This review aims to consolidate the understanding of the association between metabolic syndrome and colorectal adenoma, elucidating the interconnected mechanisms between different metabolic syndrome-related disorders and colorectal adenoma. By shedding light on these connections, this review offers valuable insights for the preventive strategies targeting colorectal adenoma.
References
[1]
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
[2]
Sun, K.X., Zheng, R.S., Zhang, S.W., et al. (2019) Analysis of the Onset and Death of Malignant Tumors in China in 2015. Chinese Tumor, 28, 1-11.
[3]
Mang, T. (2018) Kolorektales Karzinom: Rolle bildgebender Verfahren in der Vorsorge. DerRadiologe, 59, 23-34. https://doi.org/10.1007/s00117-018-0479-0
[4]
Suchanek, S., Grega, T., Ngo, O., Vojtechova, G., Majek, O., Minarikova, P., et al. (2016) How Significant Is the Association between Metabolic Syndrome and Prevalence of Colorectal Neoplasia? World Journal of Gastroenterology, 22, 8103-8111. https://doi.org/10.3748/wjg.v22.i36.8103
[5]
Siddiqui, A.A. and Palmer, B.F. (2011) Metabolic Syndrome and Its Association with Colorectal Cancer: A Review. The American Journal of the Medical Sciences, 341, 227-231. https://doi.org/10.1097/maj.0b013e3181df9055
[6]
McCracken, E., Monaghan, M. and Sreenivasan, S. (2018) Pathophysiology of the Metabolic Syndrome. Clinics in Dermatology, 36, 14-20. https://doi.org/10.1016/j.clindermatol.2017.09.004
[7]
Bétry, C., Challan-Belval, M.A., Bernard, A., Charrié, A., Drai, J., Laville, M., et al. (2015) Increased TSH in Obesity: Evidence for a BMI-Independent Association with Leptin. Diabetes & Metabolism, 41, 248-251. https://doi.org/10.1016/j.diabet.2014.11.009
[8]
Yamaji, T., Iwasaki, M., Sasazuki, S. and Tsugane, S. (2010) Interaction between Adiponectin and Leptin Influences the Risk of Colorectal Adenoma. Cancer Research, 70, 5430-5437. https://doi.org/10.1158/0008-5472.can-10-0178
[9]
Marsland, A.L., McCaffery, J.M., Muldoon, M.F. and Manuck, S.B. (2010) Systemic Inflammation and the Metabolic Syndrome among Middle-Aged Community Volunteers. Metabolism, 59, 1801-1808. https://doi.org/10.1016/j.metabol.2010.05.015
[10]
Caricilli, A.M., Picardi, P.K., de Abreu, L.L., Ueno, M., Prada, P.O., Ropelle, E.R., et al. (2016) Retraction: Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice. PLOS Biology, 14, e1002479. https://doi.org/10.1371/journal.pbio.1002479
[11]
Shen, X.J., Rawls, J.F., Randall, T.A., Burcall, L., Mpande, C., Jenkins, N., et al. (2010) Molecular Characterization of Mucosal Adherent Bacteria and Associations with Colorectal Adenomas. Gut Microbes, 1, 138-147. https://doi.org/10.4161/gmic.1.3.12360
[12]
Qu, R., Zhang, Y., Ma, Y., Zhou, X., Sun, L., Jiang, C., et al. (2023) Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer. Advanced Science, 10, e2205563. https://doi.org/10.1002/advs.202205563
[13]
Harding, J., Sooriyakumaran, M., Anstey, K.J., Adams, R., Balkau, B., Briffa, T., et al. (2015) The Metabolic Syndrome and Cancer: Is the Metabolic Syndrome Useful for Predicting Cancer Risk above and Beyond Its Individual Components? Diabetes & Metabolism, 41, 463-469. https://doi.org/10.1016/j.diabet.2015.04.006
[14]
Yu, Y. and Wu, J. (2020) Presence of Metabolic Syndrome and Thyroid Nodules in Subjects with Colorectal Polyps. Medical Science Monitor, 27, e927935. https://doi.org/10.12659/msm.927935
[15]
Fliss-Isakov, N., Zelber-Sagi, S., Webb, M., Halpern, Z., Shibolet, O. and Kariv, R. (2017) Distinct Metabolic Profiles Are Associated with Colorectal Adenomas and Serrated Polyps. Obesity (SilverSpring), 25, S72-S80. https://doi.org/10.1002/oby.22001
[16]
Kim, J.H., Lim, Y.J., Kim, Y., Sung, I., Shim, S.G., Oh, S., et al. (2007) Is Metabolic Syndrome a Risk Factor for Colorectal Adenoma? Cancer Epidemiology, Biomarkers & Prevention, 16, 1543-1546. https://doi.org/10.1158/1055-9965.epi-07-0199
[17]
Kang, H.W., Kim, D., Kim, H.J., Kim, C.H., Kim, Y.S., Park, M.J., et al. (2010) Visceral Obesity and Insulin Resistance as Risk Factors for Colorectal Adenoma: A Cross-Sectional, Case–Control Study. American Journal of Gastroenterology, 105, 178-187. https://doi.org/10.1038/ajg.2009.541
[18]
Liu, Y., Bao, L.H., Wang, T.J., et al. (2017) Analysis of BMI Index and Colon Polyps Susceptibility in Men Aged 45-60 Years. Chinese Medical Equipment, 32, 61-62.
[19]
Comstock, S.S., Hortos, K., Kovan, B., McCaskey, S., Pathak, D.R. and Fenton, J.I. (2014) Adipokines and Obesity Are Associated with Colorectal Polyps in Adult Males: A Cross-Sectional Study. PLOS ONE, 9, e85939. https://doi.org/10.1371/journal.pone.0085939
[20]
Otake, S., Takeda, H., Suzuki, Y., Fukui, T., Watanabe, S., Ishihama, K., et al. (2005) Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance. Clinical Cancer Research,11, 3642-3646. https://doi.org/10.1158/1078-0432.ccr-04-1868
[21]
Boutari, C. and Mantzoros, C.S. (2018) Inflammation: A Key Player Linking Obesity with Malignancies. Metabolism, 81, A3-A6. https://doi.org/10.1016/j.metabol.2017.12.015
[22]
Trayhurn, P. (2022) Adipokines: Inflammation and the Pleiotropic Role of White Adipose Tissue. British Journal of Nutrition, 127, 161-164. https://doi.org/10.1017/s0007114521003962
[23]
Di Zazzo, E., Polito, R., Bartollino, S., Nigro, E., Porcile, C., Bianco, A., et al. (2019) Adiponectin as Link Factor between Adipose Tissue and Cancer. International Journal of Molecular Sciences, 20, Article No. 839. https://doi.org/10.3390/ijms20040839
[24]
Kashfi, K., Rosen, C.L. and Aslan, M. (2019) Obesity, Type-2 Diabetes and Cancer: Mechanistic Insights. Critical Reviews™ in Oncogenesis, 24, 285-305. https://doi.org/10.1615/critrevoncog.2019032959
[25]
Luo, S., Li, J., Zhao, L., Yu, T., Zhong, W., Xia, Z., et al. (2016) Diabetes Mellitus Increases the Risk of Colorectal Neoplasia: An Updated Meta-Analysis. Clinics and Research in Hepatology and Gastroenterology, 40, 110-123. https://doi.org/10.1016/j.clinre.2015.05.021
[26]
Modi, S., Syed Gaggatur, N., Sange, A.H., Srinivas, N., Sarnaik, M.K., Hassan, M., et al. (2021) An Emerging Facet of Diabetes Mellitus: The Nexus of Gastrointestinal Disorders. Cureus, 13, e18245. https://doi.org/10.7759/cureus.18245
[27]
Xu, J., Ye, Y., Wu, H., Duerksen-Hughes, P., Zhang, H., Li, P., et al. (2016) Association between Markers of Glucose Metabolism and Risk of Colorectal Cancer. BMJ Open, 6, e011430. https://doi.org/10.1136/bmjopen-2016-011430
[28]
Rampal, S., Yang, M.H., Sung, J., Son, H.J., Choi, Y., Lee, J.H., et al. (2014) Association between Markers of Glucose Metabolism and Risk of Colorectal Adenoma. Gastroenterology, 147, 78-87.e3. https://doi.org/10.1053/j.gastro.2014.03.006
[29]
Yoon, Y.S., Keum, N., Zhang, X., Cho, E. and Giovannucci, E.L. (2015) Hyperinsulinemia, Insulin Resistance and Colorectal Adenomas: A Meta-Analysis. Metabolism, 64, 1324-1333. https://doi.org/10.1016/j.metabol.2015.06.013
[30]
Rodrigues Mantuano, N., Stanczak, M.A., Oliveira, I.d.A., Kirchhammer, N., Filardy, A.A., Monaco, G., et al. (2020) Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-Glcnacylation. Cancer Immunology Research, 8, 1262-1272. https://doi.org/10.1158/2326-6066.cir-19-0904
[31]
Sud, S., O’Callaghan, C., Jonker, C., Karapetis, C., Price, T., Tebbutt, N., et al. (2018) Hypertension as a Predictor of Advanced Colorectal Cancer Outcome and Cetuximab Treatment Response. Current Oncology, 25, 516-526. https://doi.org/10.3747/co.25.4069
[32]
Thaker, P.H., Han, L.Y., Kamat, A.A., Arevalo, J.M., Takahashi, R., Lu, C., et al. (2006) Chronic Stress Promotes Tumor Growth and Angiogenesis in a Mouse Model of Ovarian Carcinoma. Nature Medicine, 12, 939-944. https://doi.org/10.1038/nm1447
[33]
Zhao, L., Xu, J., Liang, F., Li, A., Zhang, Y. and Sun, J. (2015) Effect of Chronic Psychological Stress on Liver Metastasis of Colon Cancer in Mice. PLOS ONE, 10, e0139978. https://doi.org/10.1371/journal.pone.0139978
[34]
Kochi, T., Shimizu, M., Ohno, T., Baba, A., Sumi, T., Kubota, M., et al. (2013) Enhanced Development of Azoxymethane-Induced Colonic Preneoplastic Lesions in Hypertensive Rats. International Journal of Molecular Sciences, 14, 14700-14711. https://doi.org/10.3390/ijms140714700
[35]
Ji, C. and Li, Y.H. (2020) Analysis of the Correlation of the Expression of Cytokines in Chronic Inflammation and Colorectal Cancer. Chinese Experimental Diagnostics, 24, 626-627.
[36]
Tran, P.H.L., Lee, B. and Tran, T.T.D. (2021) Current Studies of Aspirin as an Anticancer Agent and Strategies to Strengthen Its Therapeutic Application in Cancer. Current Pharmaceutical Design, 27, 2209-2220. https://doi.org/10.2174/1381612826666201102101758
[37]
Yang, Z., Tang, H., Lu, S., Sun, X. and Rao, B. (2022) Relationship between Serum Lipid Level and Colorectal Cancer: A Systemic Review and Meta-Analysis. BMJ Open, 12, e052373. https://doi.org/10.1136/bmjopen-2021-052373
[38]
Wang, J.C., Ji, Y., Zhou, J., et al. (2016) Mechanisms of Oxidative Damage in the Disturbance of Triacylglycerol Metabolism in Hypertriglyceridemic Rats. Journal of Clinical Rational Drug Use, 9, 109-110.
[39]
Ramadas, A. and Kandiah, M. (2009) Food Intake and Colorectal Adenomas: A Case-Control Study in Malaysia. Asian Pacific Journal of Cancer Prevention,10, 925-932.
[40]
Shan, H., Zhang, R., Li, Y., Xu, G., Luo, G., Gao, X., et al. (2011) Expression of IGF-1R in Colorectal Polyps and Its Role in Colorectal Carcinogenesis. Technology in Cancer Research & Treatment, 10, 381-389. https://doi.org/10.7785/tcrt.2012.500215
[41]
Saetang, J. and Sangkhathat, S. (2017) Diets Link Metabolic Syndrome and Colorectal Cancer Development. Oncology Reports, 37, 1312-1320. https://doi.org/10.3892/or.2017.5385
